Search Results

There are 9008 results for: content related to: Effect of Valsartan With Bedtime Dosing on Chronic Kidney Disease Patients With Nondipping Blood Pressure Pattern

  1. Inhibitory Effect of Valsartan on the Intestinal Absorption and Renal Excretion of Bestatin in Rats

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 2, February 2014, Pages: 719–729, Xiaokui Huo, Qi Liu, Changyuan Wang, Qiang Meng, Huijun Sun, Jinyong Peng, Xiaochi Ma, Pengyuan Sun and Kexin Liu

    Version of Record online : 11 DEC 2013, DOI: 10.1002/jps.23805

  2. You have free access to this content
    Comparative Efficacy of Aliskiren/Valsartan vs Valsartan in Nocturnal Dipper and Nondipper Hypertensive Patients: A Pooled Analysis

    The Journal of Clinical Hypertension

    Volume 14, Issue 5, May 2012, Pages: 299–306, Thomas D. Giles, 1 Thomas Alessi, 2 Das Purkayastha and 2 Dion Zappe 2

    Version of Record online : 16 MAR 2012, DOI: 10.1111/j.1751-7176.2012.00608.x

  3. Evaluation of Pharmacokinetic Interactions Between Amlodipine, Valsartan, and Hydrochlorothiazide in Patients With Hypertension

    The Journal of Clinical Pharmacology

    Volume 51, Issue 6, June 2011, Pages: 933–942, Mr Prafulla Bhad, Dr Surya Ayalasomayajula, Dr Rajesh Karan, Dr Selene Leon, Dr Gillies-Jacques Riviere, Dr Gangadhar Sunkara and Dr Venkateswar Jarugula

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010376963

  4. You have full text access to this OnlineOpen article
    Valsartan independent of AT1 receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions

    Journal of Cellular and Molecular Medicine

    Volume 18, Issue 10, October 2014, Pages: 2031–2043, Yu Mi Ha, Eun Jung Park, Young Jin Kang, Sang Won Park, Hye Jung Kim and Ki Churl Chang

    Version of Record online : 11 AUG 2014, DOI: 10.1111/jcmm.12354

  5. You have free access to this content
    Treating Systolic Hypertension in the Very Elderly With Valsartan-Hydrochlorothiazide vs Either Monotherapy: ValVET Primary Results

    The Journal of Clinical Hypertension

    Volume 13, Issue 10, October 2011, Pages: 722–730, Joseph L. Izzo Jr, Howard S. Weintraub, Daniel A. Duprez, Das Purkayastha, Dion Zappe, Rita Samuel and William C. Cushman

    Version of Record online : 14 JUL 2011, DOI: 10.1111/j.1751-7176.2011.00498.x

  6. You have full text access to this OnlineOpen article
    Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 8, August 2015, Pages: 1773–1782, Xizhong Sui, Hongchao Wei and Dacheng Wang

    Version of Record online : 30 MAR 2015, DOI: 10.1111/jcmm.12551

  7. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats

    Diabetes, Obesity and Metabolism

    Volume 9, Issue 1, January 2007, Pages: 39–49, P. Chan, I.-M. Liu, T.-F. Tzeng, T.-L. Yang and J.-T. Cheng

    Version of Record online : 27 FEB 2006, DOI: 10.1111/j.1463-1326.2005.00566.x

  8. Effect of food on the oral bioavailability of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide fixed dose combination tablets in healthy subjects

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 6, November/December 2014, Pages: 487–492, Gangadhar Sunkara, Xuemin Jiang, Christine Reynolds, Denise Serra, Yiming Zhang, Monica Ligueros-Saylan, Surya Ayalasomayajula, Serge Winter and Venkateswar Jarugula

    Version of Record online : 2 JUN 2014, DOI: 10.1002/cpdd.131

  9. Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi)

    The Journal of Clinical Pharmacology

    Volume 50, Issue 4, April 2010, Pages: 401–414, Dr Jessie Gu, Dr Adele Noe, Dr Priya Chandra, Dr Suliman Al-Fayoumi, Dr Monica Ligueros-Saylan, Dr Ramesh Sarangapani, Dr Suzanne Maahs, Dr Gary Ksander, Dr Dean F. Rigel, Dr Arco Y. Jeng, Dr Tsu-Han Lin, Dr Weiyi Zheng and Dr William P. Dole

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009343932

  10. You have free access to this content
    Randomized Study of Antihypertensive Efficacy and Safety of Combination Aliskiren/Valsartan vs Valsartan Monotherapy in Hypertensive Participants With Type 2 Diabetes Mellitus

    The Journal of Clinical Hypertension

    Volume 15, Issue 2, February 2013, Pages: 92–100, George L. Bakris, Suzanne Oparil, Das Purkayastha, Anthony M. Yadao, Thomas Alessi and James R. Sowers

    Version of Record online : 26 OCT 2012, DOI: 10.1111/jch.12032

  11. You have free access to this content
    Effectiveness and Safety of Valsartan in Children Aged 6 to 16 Years With Hypertension

    The Journal of Clinical Hypertension

    Volume 13, Issue 5, May 2011, Pages: 357–365, Thomas Wells, Jeffrey Blumer, Kevin E.C. Meyers, Jose P.R. Neto, Rejane Meneses, Mieczysław Litwin, Johan Vande Walle, Susan Solar-Yohay, Victor Shi, Guangyang Han and The Valsartan Pediatric Hypertension Study Group

    Version of Record online : 18 MAR 2011, DOI: 10.1111/j.1751-7176.2011.00432.x

  12. Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 48, Issue 1, January 2008, Pages: 85–95, Dr Yan-Ling He, Dr Monica Ligueros-Saylan, Dr Gangadhar Sunkara, Dr Ron Sabo, Dr Charlie Zhao, Dr Yibin Wang, Dr Joelle Campestrini, Dr Françoise Pommier, Dr Kiran Dole, Dr Alan Marion, Dr Willia P. Dole and Dr Dan Howard

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007307880

  13. Pharmacokinetics of Valsartan in Pediatric and Adolescent Subjects With Hypertension

    The Journal of Clinical Pharmacology

    Volume 49, Issue 2, February 2009, Pages: 235–241, Dr Jeffrey Blumer, Dr Donald L. Batisky, Dr Thomas Wells, Dr Victor Shi, Ms Susan Solar-Yohay and Dr Gangadhar Sunkara

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008329547

  14. You have free access to this content
    The Efficacy and Safety of Valsartan in Obese and Non-Obese Pediatric Hypertensive Patients

    The Journal of Clinical Hypertension

    Volume 13, Issue 10, October 2011, Pages: 758–766, Kevin E. C. Meyers, Kenneth Lieberman, Susan Solar-Yohay, Guangyang Han and Victor Shi

    Version of Record online : 14 JUL 2011, DOI: 10.1111/j.1751-7176.2011.00502.x

  15. Alteration of the intravenous and oral pharmacokinetics of valsartan via the concurrent use of gemfibrozil in rats

    Biopharmaceutics & Drug Disposition

    Volume 37, Issue 5, July 2016, Pages: 245–251, Seung Jun Yang, Bong Jin Kim, Lingxuan Mo and Hyo-Kyung Han

    Version of Record online : 20 JUL 2016, DOI: 10.1002/bdd.2001

  16. The benefits of valsartan in the treatment of heart failure: results from Val-HeFT

    International Journal of Clinical Practice

    Volume 58, Issue 2, February 2004, Pages: 184–191, L-B Tan, 1 D. Schlosshan and 1 S. G. Williams 2

    Version of Record online : 8 MAR 2004, DOI: 10.1111/j.1368-5031.2004.0134.x

  17. You have free access to this content
    Improving Blood Pressure Control: Increase the Dose of Diuretic or Switch to a Fixed-Dose Angiotensin Receptor Blocker/Diuretic? The Valsartan Hydrochlorothiazide Diuretic for Initial Control and Titration to Achieve Optimal Therapeutic Effect (Val-DICTATE) Trial

    The Journal of Clinical Hypertension

    Volume 10, Issue 6, June 2008, Pages: 450–458, William B. White, David A. Calhoun, Rita Samuel, Addison A. Taylor, Dion H. Zappe and Das Purkayastha

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1751-7176.2008.08259.x

  18. Quantitative model for the blood pressure-lowering interaction of valsartan and amlodipine

    British Journal of Clinical Pharmacology

    Volume 82, Issue 6, December 2016, Pages: 1557–1567, Young-A Heo, Nick Holford, Yukyung Kim, Mijeong Son and Kyungsoo Park

    Version of Record online : 3 OCT 2016, DOI: 10.1111/bcp.13082

  19. Bioavailability of valsartan oral dosage forms

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 2, March/April 2014, Pages: 132–138, Gangadhar Sunkara, Girish Bende, Anisha E. Mendonza, Susan Solar-Yohay, Shibadas Biswal, Srikanth Neelakantham, Robert Wagner, Jimmy Flarakos, Yiming Zhang and Venkateswar Jarugula

    Version of Record online : 10 OCT 2013, DOI: 10.1002/cpdd.56

  20. You have free access to this content
    Metabolic and Antihypertensive Effects of Combined Angiotensin Receptor Blocker and Diuretic Therapy in Prediabetic Hypertensive Patients With the Cardiometabolic Syndrome

    The Journal of Clinical Hypertension

    Volume 10, Issue 12, December 2008, Pages: 894–903, Dion H. Zappe, James R. Sowers, Willa A. Hsueh, Steven M. Haffner, Prakash C. Deedwania, Vivian A. Fonseca, Lucy Keeling and Domenic A. Sica

    Version of Record online : 5 DEC 2008, DOI: 10.1111/j.1751-7176.2008.00054.x